Source 1primary paper2025MED
Toolkit/CRISPR screening
CRISPR screening
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Personalization using advanced technologies like CRISPR screening and single-cell RNA sequencing can enhance durability and effectiveness of treatments for heavily pretreated patients
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete method used to build, optimize, or evolve an engineered system.
Mechanisms
selectionTarget processes
editingrecombinationselectionValidation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Multi-targeting strategies including logic-gated CARs, adapter CARs, and combination therapies can increase CAR-T cell potency and aim to minimize immune evasion by simultaneously targeting multiple antigens.
multi-targeting strategies like logic-gated CARs, adapter CARs, or combination therapies can increase the potency of CAR-T cells. These approaches aim to minimize immune evasion by targeting multiple antigens simultaneously
Single-antigen CAR-T therapies can fail through immune evasion caused by antigen escape.
most CAR-T therapies target a single antigen, such as CD19, which can result in immune evasion through antigen escape
CRISPR screening and single-cell RNA sequencing can support personalization that enhances durability and effectiveness of treatments for heavily pretreated patients.
Personalization using advanced technologies like CRISPR screening and single-cell RNA sequencing can enhance durability and effectiveness of treatments for heavily pretreated patients
NGS, dSTORM, and multiparametric flow cytometry help identify novel tumor-specific targets and improve CAR-T therapy designs.
advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs
Approval Evidence
1 source1 linked approval claimfirst-pass slug crispr-screening
Personalization using advanced technologies like CRISPR screening and single-cell RNA sequencing can enhance durability and effectiveness of treatments for heavily pretreated patients
Source:
use casesupports
CRISPR screening and single-cell RNA sequencing can support personalization that enhances durability and effectiveness of treatments for heavily pretreated patients.
Personalization using advanced technologies like CRISPR screening and single-cell RNA sequencing can enhance durability and effectiveness of treatments for heavily pretreated patients
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.